SCHEMBL30475882

SCHEMBL30475882

C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CC(=O)O)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 15/20 0.49
▸ NPY1R P25929 9/20 0.49
▸ NPY5R Q15761 8/20 0.49
▸ NPY2R P49146 5/20 0.49
▸ TUBB4A P04350 1/20 0.44
▸ TUBB P07437 1/20 0.44
▸ TUBA3C P0DPH7 1/20 0.44
▸ TUBA1B P68363 1/20 0.44
▸ TUBA4A P68366 1/20 0.44
▸ TUBB4B P68371 1/20 0.44
▸ TUBB3 Q13509 1/20 0.44
▸ TUBB2A Q13885 1/20 0.44
▸ TUBB8 Q3ZCM7 1/20 0.44
▸ TUBA3E Q6PEY2 1/20 0.44
▸ TUBA1A Q71U36 1/20 0.44
▸ TUBA1C Q9BQE3 1/20 0.44
▸ TUBB6 Q9BUF5 1/20 0.44
▸ TUBB2B Q9BVA1 1/20 0.44
▸ TUBB1 Q9H4B7 1/20 0.44
▸ PTPN1 P18031 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29476637 0.93 NPY4R (0.45) NPY4RNPY1RNPY5RNPY2RTUBB4A
SCHEMBL29889197 0.93 NPY4R (0.49) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL30475880 0.93 NPY4R (0.49) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL29889146 0.92 NPY4R (0.46) NPY4RNPY1RNPY5RNPY2RTUBB4A
SCHEMBL29482469 0.91 NPY4R (0.45) NPY4RNPY1RNPY5RNPY2RTUBB4A
SCHEMBL30475873 0.91 NPY4R (0.45) NPY4RNPY1RNPY5RNPY2RTUBB4A
SCHEMBL29387939 0.91 PTPN1 (0.48) NPY4RNPY1RNPY5RPTPN1GLP1R
SCHEMBL30475874 0.89 NPY4R (0.49) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL29634991 0.89 NPY4R (0.50) NPY4RNPY1RNPY5RNPY2RTUBB4A
SCHEMBL30475877 0.89 NPY4R (0.46) NPY4RNPY1RNPY5RNPY2RPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212549-A1 COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2023-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212549-A1 COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF FIBP, FN1, TPX2 NPY4R 199/4885NPY1R 160/4885NPY5R 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback